Domvanalimab Clinical Trials
3 recruitingDrug
Phase 22Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
Non-small Cell Lung Cancer
AstraZeneca860 enrolled264 locationsNCT05211895
Recruiting
Phase 2
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Metastatic Urothelial Cancer
Gilead Sciences827 enrolled135 locationsNCT03547973
Recruiting
Phase 2
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma
Melanoma
Diwakar Davar26 enrolled1 locationNCT05130177